CPI

CPI Card Group Inc. to Release Fourth Quarter Results on March 7, 2024

Retrieved on: 
Thursday, February 22, 2024

CPI Card Group Inc. (Nasdaq: PMTS) (“CPI Card Group”), a payment technologies company and leading provider of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service-based instant issuance, today announced it will host a webcast and conference call on Thursday March 7, 2024 at 9:00 a.m. Eastern Time (ET) to discuss its fourth quarter and full year 2023 financial results.

Key Points: 
  • CPI Card Group Inc. (Nasdaq: PMTS) (“CPI Card Group”), a payment technologies company and leading provider of credit, debit, and prepaid card and digital solutions, including Software-as-a-Service-based instant issuance, today announced it will host a webcast and conference call on Thursday March 7, 2024 at 9:00 a.m. Eastern Time (ET) to discuss its fourth quarter and full year 2023 financial results.
  • CPI Card Group’s financial results for the fourth quarter will be released before the markets open on March 7, 2024.
  • The press release and a slide presentation to accompany the earnings conference call will be available on the CPI Card Group investor website: CPI Card Group - Investor Relations ( https://investor.cpicardgroup.com ).
  • A replay of the conference call will be available until March 21, 2024 at:
    A webcast replay of the conference call will also be available on CPI Card Group Inc.’s Investor Relations web site: https://investor.cpicardgroup.com

Targets set in 2024 Government Work Report

Retrieved on: 
Thursday, March 7, 2024

BEIJING, March 6, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn:

Key Points: 
  • BEIJING, March 6, 2024 /PRNewswire/ -- A news report from chinadaily.com.cn:
    China's government has set the 2024 growth target at around 5 percent, new urban jobs at over 12 million, CPI up around 3 percent, and general public expenditures in government budget reaching 28.5 trillion yuan.
  • China will further develop new quality productive forces at a faster pace, foster emerging industries and future-oriented industries, and launch the AI Plus initiative in 2024.
  • This year, China aims to keep basic equilibrium in balance of payments, boost imports of high-quality goods, intensify efforts to attract foreign investment, and create a sound environment in which enterprises under all forms of ownership can compete and grow on a level playing field.
  • View original content to download multimedia: https://www.prnewswire.com/news-releases/targets-set-in-2024-government-...

China's 5% growth target continues to play vital role in world economy: Global Times editorial

Retrieved on: 
Wednesday, March 6, 2024

China's contribution to world economic growth is expected to continue to exceed 30 percent, making it the largest driving force of the global economy.

Key Points: 
  • China's contribution to world economic growth is expected to continue to exceed 30 percent, making it the largest driving force of the global economy.
  • As always, China's GDP growth target has attracted great attention at home and abroad, which bears practical connotations.
  • In general, the growth target of around 5 percent is considered prudent, appropriate and pragmatically positive by public opinion.
  • China's economy is transitioning from a period of high-speed growth to medium-high-speed growth, entering a phase of high-quality development.

Crisis Prevention Institute Releases Prevention First™ Online Training to Help Health Care Professionals Feel Safer at Work

Retrieved on: 
Tuesday, March 5, 2024

MILWAUKEE, March 5, 2024 /PRNewswire-PRWeb/ -- Crisis Prevention Institute (CPI) has launched Prevention First™ Online Training, a new, 30-minute, on-demand training to provide health care professionals with the skills they need to foster a safer workplace, including proactively recognizing and preventing escalating situations of harassment, aggression and violence. CPI designed Prevention First specifically for health care professionals' busy schedules and to limit their time off the floor.

Key Points: 
  • Crisis Prevention Institute (CPI) has launched Prevention First™ Online Training, a new, 30-minute, on-demand training to provide health care professionals with the skills they need to foster a safer workplace, including proactively recognizing and preventing escalating situations of harassment, aggression and violence.
  • MILWAUKEE, March 5, 2024 /PRNewswire-PRWeb/ -- Crisis Prevention Institute (CPI) has launched Prevention First ™ Online Training, a new, 30-minute, on-demand training to provide health care professionals with the skills they need to foster a safer workplace, including proactively recognizing and preventing escalating situations of harassment, aggression and violence.
  • CPI designed Prevention First specifically for health care professionals' busy schedules and to limit their time off the floor.
  • Prevention First helps health care organizations build a common language that improves collaboration and aligns staff across all departments during a crisis.

Advarra Hires Clinical Research Industry Veteran Christine Senn to Bring Sites and Sponsors Together, Driving Speed Not Siloes

Retrieved on: 
Tuesday, March 5, 2024

COLUMBIA, Md., March 5, 2024 /PRNewswire/ -- Advarra, the market leader in regulatory review solutions and clinical research technology for sites and sponsors, welcomes clinical industry veteran Christine Senn, PhD, as Senior Vice President, Head of Site-Sponsor Innovation. With extensive site leadership experience and a longstanding personal goal to drive site-sponsor collaboration, Senn will lead Advarra's effort to remove barriers between stakeholders and connect a siloed clinical research ecosystem – ultimately, to accelerate clinical trials.

Key Points: 
  • COLUMBIA, Md., March 5, 2024 /PRNewswire/ -- Advarra , the market leader in regulatory review solutions and clinical research technology for sites and sponsors, welcomes clinical industry veteran Christine Senn , PhD, as Senior Vice President, Head of Site-Sponsor Innovation.
  • She will also drive and oversee the development of innovative ways to bring clinical trial sites and sponsors together in support of Advarra's mission.
  • "Fostering collaboration of all clinical research stakeholders has been important to me throughout my career," said Christine Senn.
  • Onsemble is the industry's largest gathering of clinical research site professionals, including cancer centers, children's hospitals, research consortia, academic medical centers, healthcare systems, and more.

Liftoff Mobile Ad Creative Index Reveals UGC and Interstitial Ads Are Key to Unlocking Advertising ROI

Retrieved on: 
Monday, March 4, 2024

SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Liftoff, the leading growth acceleration platform for the mobile industry, has unveiled its sixth annual Mobile Ad Creative Index. The report analyzes trends across four key app verticals: gaming, e-commerce, finance, and entertainment.

Key Points: 
  • However, gaming ads with a video or playable element have a much higher chance of driving an install than banner ads.
  • That said, native and banner ads still generate the most ROI 7 days post-install, with native ads at 20.26% and banner ads at 18.20%.
  • The 2024 Mobile Ad Creative Index report, published by Liftoff, presents a comprehensive analysis of the mobile advertising landscape.
  • The report evaluates the effectiveness of various mobile ad formats, including banners, interstitials, playables, videos, and native ads.

Liftoff Mobile Ad Creative Index Reveals UGC and Interstitial Ads Are Key to Unlocking Advertising ROI

Retrieved on: 
Monday, March 4, 2024

SAN FRANCISCO, March 4, 2024 /PRNewswire/ -- Liftoff, the leading growth acceleration platform for the mobile industry, has unveiled its sixth annual Mobile Ad Creative Index. The report analyzes trends across four key app verticals: gaming, e-commerce, finance, and entertainment.

Key Points: 
  • However, gaming ads with a video or playable element have a much higher chance of driving an install than banner ads.
  • That said, native and banner ads still generate the most ROI 7 days post-install, with native ads at 20.26% and banner ads at 18.20%.
  • The 2024 Mobile Ad Creative Index report, published by Liftoff, presents a comprehensive analysis of the mobile advertising landscape.
  • The report evaluates the effectiveness of various mobile ad formats, including banners, interstitials, playables, videos, and native ads.

Michael Cosgrove honored with Lawrence R. Klein Award for Blue Chip Forecasting

Retrieved on: 
Monday, February 26, 2024

TEMPE, Ariz., Feb. 26, 2024 /PRNewswire/ -- As economic analysts continue to debate the prospects for a soft landing versus a hard fall for the U.S. economy, Michael Cosgrove, principal and founder of The Econoclast®, Inc., predicts a mild recession with more disinflation and at least 100 basis points decline in the funds rate. Cosgrove is being honored with the Lawrence R. Klein Award for Blue Chip Forecast Accuracy for 2023, one of the best-known and longest-standing achievements in economic forecasting.

Key Points: 
  • Cosgrove is being honored with the Lawrence R. Klein Award for Blue Chip Forecast Accuracy for 2023, one of the best-known and longest-standing achievements in economic forecasting.
  • A livestream of the forecast and award ceremony will also be available, and is free for the public to view.
  • Register here to attend the live presentation of the Lawrence R. Klein Award at the University Club of New York on March 6, from 6 to 8 p.m. Eastern.
  • Cosgrove has been a long-term participant in the Blue Chip Economic Indicators, The Wall Street Journal survey, Western Blue Chip Economic Forecast, and Pulsenomics, and had best home price forecast at Pulsenomics in 2014.

WSWA's SipSource Report Tracks 2023 Year-End Losses for Both Wine and Spirits

Retrieved on: 
Wednesday, February 21, 2024

WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Wine & Spirits Wholesalers of America (WSWA)'s SipSource, the only source for verified wine and spirits distributor depletion data that covers sales to hundreds of thousands of retailers across the country, yesterday released year-ending data for 2023. The Q4 2023 SipSource Report identifies year-end losses for both wine and spirits, individual category trends, demographic data, and explores commercial and consumer behaviors that contributed to the market's current state. The report focuses on data over a 12-month period (January 2023 to December 2023), predicts what consumer trends will bring for both the on- and off-premise in 2024, and gives short- and long-term insight and understanding for the industry's future.

Key Points: 
  • WASHINGTON, Feb. 21, 2024 /PRNewswire/ -- Wine & Spirits Wholesalers of America (WSWA)'s SipSource, the only source for verified wine and spirits distributor depletion data that covers sales to hundreds of thousands of retailers across the country, yesterday released year-ending data for 2023.
  • The Q4 2023 SipSource Report identifies year-end losses for both wine and spirits, individual category trends, demographic data, and explores commercial and consumer behaviors that contributed to the market's current state.
  • Combined wine and spirits depletion volumes were down -5.6% in 2023 with wine down -7.5% and spirits falling -3.6%.
  • The ready-to-drink (RTD) category across both wine and spirits was a rare bright spot of growth, with pre-mixed cocktails (wine) ending 2023 with +0.5% growth and pre-mixed cocktails (spirits) growing +6.3%.

Medicenna Announces First Patient Dosed in ABILITY-1 Study of MDNA11 in Combination with KEYTRUDA® (pembrolizumab) in Patients with Advanced Solid Tumors

Retrieved on: 
Tuesday, February 13, 2024

The combination portion of the study is designed to evaluate the potential for a synergistic effect of MDNA11 with KEYTRUDA® in patients with advanced solid tumors.

Key Points: 
  • The combination portion of the study is designed to evaluate the potential for a synergistic effect of MDNA11 with KEYTRUDA® in patients with advanced solid tumors.
  • “Dosing the first patient in the combination arm with MDNA11 and KEYTRUDA® is a significant milestone for Medicenna and are excited with the progress of our novel IL-2 superkine," said Fahar Merchant, PhD, President and CEO of Medicenna.
  • “By combining MDNA11 with KEYTRUDA®, we are building upon the promising data generated to date by MDNA11 as a single agent.
  • MDNA11, with its uniquely differentiating ‘beta-enhanced not-alpha’ features, continues to be a potential best-in-class next-generation IL-2 super-agonist for treatment of advanced solid tumors.